Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus
Jiankai Liang(Sun Yat-sen University), Guangmei Yan(Sun Yat-sen University), Yaqian Tan(Guangzhou Medical University), Jun Hu(China University of Geosciences), Chuntao Li(Sun Yat-sen University), Xincheng Liu(Sun Yat-sen University), Jing Cai(Shandong University), Li Guo(Sun Yat-sen University), Kai Li(China University of Geosciences (Beijing)), Yuan Lin(Sun Yat-sen University), Ying Liu(Sun Yat-sen University), Haipeng Zhang(Jinan University), Songmin He(Cornell University), Wenbo Zhu(Sun Yat-sen University), Yaya Yu(Guangzhou University of Chinese Medicine), Cheng Hu(Shenzhen Second People's Hospital), Xiao Xiao(Guangdong Academy of Medical Sciences), Xingwen Su(Sun Yat-sen University), Pengxin Qiu, Xiaoke Zheng(Henan Bioengineering Technology Research Center)
Cited by 27
Related Papers
Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers
|Proceedings of the National Academy of Sciences|2014|167
Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells
|Molecular Cancer|2011|139
The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes
|Cell Reports|2017|124
Bibliometric and Visual Analysis of Research on the Links Between the Gut Microbiota and Depression From 1999 to 2019
|Frontiers in Psychiatry|2021|90
Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma
|Science Translational Medicine|2017|84